Carregant...
Drug repurposing for COVID-19: Approaches, challenges and promising candidates
Traditional drug development and discovery has not kept pace with threats from emerging and re-emerging diseases such as Ebola virus, MERS-CoV and more recently, SARS-CoV-2. Among other reasons, the exorbitant costs, high attrition rate and extensive periods of time from research to market approval...
Guardat en:
| Publicat a: | Pharmacol Ther |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier Inc.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8220862/ https://ncbi.nlm.nih.gov/pubmed/34174275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2021.107930 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|